Camber is a unique sales and marketing organization with a mission to provide exceptional value and unmatched service in generic drugs.

Fully supported by the worlds leading API and finished dosage company, Hetero of Hyderabad India, Camber is one of the fastest growing generic drug companies in the USA.

As a leading innovation-driven corporation, Hetero is developing a growing portfolio of pharmaceutical products to meet some of the world's most urgent medical needs. Today Hetero is manufacturing a product portfolio of over 200 products in major therapeutic areas, with an emphasis on antiretroviral, gastro-intestinal, cardiovascular, antidepressants/antipsychotics, antidiabetics, pain management, anti-infectives, dermatology and oncology.  

From API to finished dosage, we own it!

  • Facilities and joint ventures in the US, India, South America, Spain and the Middle East  
  • Total control of the supply chain
  • Over 400 scientists in API and finished dosage R&D
  • 11 API facilities - 6 FDA approved
  • Over 100 DMFs filed
  • Global presence in over 100 countries

New Facilities Increase Efficiencies

Our new 60,000 square foot distribution and office facility has enabled Camber to add the staff and resources necessary to maximize efficiencies, improve logistics and increase the already impressive integrity of our supply chain.


Our technical and global resources are your distinct advantage

Ever since its inception, Camber has shown a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.

Through its parent company, Hetero, Camber is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization. Research & Development is the foundation of Hetero's philosophy of developing cost-effective, high quality and safe medicines to society. Hetero has a team of over 400 dedicated scientists working in the areas of Process, Analytical and Discovery Research.

Growing to meet the needs of today's generics marketplace

Camber's product strategy is simple- Capitalize on our core strengths to deliver maximum profitability to our customers. We accomplish this by leveraging a flexible corporate structure, providing a broad product line and maintaining an unwavering commitment to quality, value and service. This philosophy has enabled Camber to grow significantly over the past several years and we will do everything possible to continue to exceed our customer's expectations.

Camber's diverse product line

Our plans include filing up 20 ANDA's a year and broadening our increasingly comprehensive product line.

Products and pipeline include:
  • Solid Orals
  • Semi-solids and Soft Gels
  • Liquids: Solutions and Suspensions
  • Specialty Products
  • Injectables and Inhalers